Skip to main navigation Skip to search Skip to main content

Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis

  • Bruce C. Trapnell
  • , Karen Maguiness
  • , Gavin Graff
  • , David Boyd
  • , Katrin Beckmann
  • , Steven Caras

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science